Waltham, MA, USA (November 10, 2025)—ACD/Labs is pleased to share that Revvity, Inc. has entered into a definitive agreement to acquire ACD/Labs. The acquisition will expand the breadth and depth of Revvity Signals’ solutions and bridge the gap between analytical data and actionable insights.
“For more than three decades, our scientists, informaticians, and software developers have been recognized as leaders in analytical and chemical intelligence,” said Daria Thorp, president and CEO of ACD/Labs. “Joining the Revvity Signals team brings together two industry leaders with a shared commitment to innovation in scientific software. Together, we will expand the reach of our technology and deliver unified, end-to-end solutions that empower customers with deeper insight and greater scientific continuity.”